MRI-compatible neurostimulator goes to work relieving pain

Dave Pearson | | Health Imaging | Diagnostic Imaging

A 62-year-old Pennsylvania man has become the first in the world to be implanted with a neurotransmitter that both blocks spinal pain and safely stands up to MRI scanning, according to The Intelligencer of Doylestown, Pa.

MRI exams, of course, are key to managing the care of patients with chronic spinal pain.

“All patients with a spinal cord stimulation system should have the ability to be offered the same imaging options as those without one,” says Steven Falowski, MD, chief of functional neurosurgery at St. Luke’s University Health Network in Bethlehem.

Click below for the story, which includes video news coverage:

Medical history made at St. Luke’s in Quakertown

Dave Pearson
Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Related Content

AI rules out abnormal findings on chest X-rays, significantly reducing workloads
Older adults among the walking wounded with incident TBI
Philips moves digital pathology to the cloud with AWS
PHOTO GALLERY: What does fetal medical imaging look like?
Speaker laments radiology’s major contribution to climate change
Radiologist accuracy takes a hit overnight, especially with advanced imaging exams

Around the web

Cardiovascular Business
Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.